Overall survival with darolutamide vs placebo in combination with androgen-deprivation therapy and docetaxel by stratification factors in the phase 3 ARASENS trial

Bertrand Tombal, Maha Hussain, Fred Saad, Karim Fizazi, Cora Sternberg, E David Crawford, Evgeny Kopyltsov, Arash Rezazadeh Kalebasty, Boris Alekseev, Álvaro Montesa-Pino, Dingwei Ye, Francis Parnis, Cruz Felipe Melo, Teuvo Tammela, Hiroyoshi Suzuki, Heikki Joensuu, Silke Thiele, Rui Li, Iris Kuss, Matthew R. Smith

Research output: Other conference contributionAbstractScientific

Original languageEnglish
Publication statusPublished - 4 Jul 2022
Publication typeNot Eligible
EventEAU22 - Amsterdam, Netherlands
Duration: 1 Jul 20224 Jul 2022
https://eaucongress.uroweb.org/scientific-programme/

Conference

ConferenceEAU22
Country/TerritoryNetherlands
CityAmsterdam
Period1/07/224/07/22
Internet address

Cite this